

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.65773541 |
| 2 | proteasome assembly (GO:0043248) | 5.73498437 |
| 3 | cytidine deamination (GO:0009972) | 5.37232724 |
| 4 | cytidine metabolic process (GO:0046087) | 5.37232724 |
| 5 | cytidine catabolic process (GO:0006216) | 5.37232724 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.98150796 |
| 7 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.77540434 |
| 8 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.40674578 |
| 9 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.26578490 |
| 10 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.25836342 |
| 11 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.25836342 |
| 12 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.08329596 |
| 13 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.00062007 |
| 14 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.00062007 |
| 15 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.00062007 |
| 16 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.98964872 |
| 17 | negative regulation of ligase activity (GO:0051352) | 3.98964872 |
| 18 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.96598545 |
| 19 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.96598545 |
| 20 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.96450414 |
| 21 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.89981312 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.86962054 |
| 23 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.86612142 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.83697670 |
| 25 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.78958354 |
| 26 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.78958354 |
| 27 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.73000306 |
| 28 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.68230265 |
| 29 | T cell migration (GO:0072678) | 3.64787929 |
| 30 | regulation of T cell tolerance induction (GO:0002664) | 3.57849995 |
| 31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.55181517 |
| 32 | B cell mediated immunity (GO:0019724) | 3.53205650 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.52230846 |
| 34 | cullin deneddylation (GO:0010388) | 3.46555210 |
| 35 | protein deneddylation (GO:0000338) | 3.36781519 |
| 36 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.26397399 |
| 37 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.23000574 |
| 38 | chaperone-mediated protein transport (GO:0072321) | 3.21614067 |
| 39 | ribosome assembly (GO:0042255) | 3.19059934 |
| 40 | regulation of chronic inflammatory response (GO:0002676) | 3.10914340 |
| 41 | protein neddylation (GO:0045116) | 3.10808589 |
| 42 | positive regulation of ligase activity (GO:0051351) | 3.09648738 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.07764380 |
| 44 | regulation of cellular amine metabolic process (GO:0033238) | 3.06812560 |
| 45 | dendritic cell chemotaxis (GO:0002407) | 3.04666885 |
| 46 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.04253104 |
| 47 | respiratory chain complex IV assembly (GO:0008535) | 3.01448933 |
| 48 | positive regulation of cell cycle arrest (GO:0071158) | 2.97817782 |
| 49 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.94485027 |
| 50 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.92417479 |
| 51 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.91170192 |
| 52 | rRNA modification (GO:0000154) | 2.90296640 |
| 53 | regulation of tolerance induction (GO:0002643) | 2.88136303 |
| 54 | positive regulation of defense response to virus by host (GO:0002230) | 2.86893052 |
| 55 | negative regulation of protein ubiquitination (GO:0031397) | 2.86825808 |
| 56 | cyclooxygenase pathway (GO:0019371) | 2.84486099 |
| 57 | regulation of antigen processing and presentation (GO:0002577) | 2.84027598 |
| 58 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.81860990 |
| 59 | isotype switching (GO:0045190) | 2.81860990 |
| 60 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.81860990 |
| 61 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.80555372 |
| 62 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.79197446 |
| 63 | response to interferon-beta (GO:0035456) | 2.79130494 |
| 64 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.79080260 |
| 65 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.77815405 |
| 66 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.75799615 |
| 67 | positive regulation of tolerance induction (GO:0002645) | 2.73550295 |
| 68 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.73526782 |
| 69 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.73199109 |
| 70 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.71023680 |
| 71 | regulation of T-helper 1 type immune response (GO:0002825) | 2.70793003 |
| 72 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.68789647 |
| 73 | regulation of ligase activity (GO:0051340) | 2.68571562 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.67624987 |
| 75 | purine nucleobase biosynthetic process (GO:0009113) | 2.67260054 |
| 76 | IMP biosynthetic process (GO:0006188) | 2.67043404 |
| 77 | tryptophan metabolic process (GO:0006568) | 2.64327609 |
| 78 | purine-containing compound salvage (GO:0043101) | 2.63454792 |
| 79 | myeloid dendritic cell activation (GO:0001773) | 2.62828277 |
| 80 | cytochrome complex assembly (GO:0017004) | 2.62799437 |
| 81 | kynurenine metabolic process (GO:0070189) | 2.62208986 |
| 82 | tolerance induction (GO:0002507) | 2.61700438 |
| 83 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.61246878 |
| 84 | lymphocyte chemotaxis (GO:0048247) | 2.59139974 |
| 85 | negative regulation of T cell apoptotic process (GO:0070233) | 2.57179968 |
| 86 | platelet dense granule organization (GO:0060155) | 2.56512891 |
| 87 | regulation of cellular extravasation (GO:0002691) | 2.56043070 |
| 88 | ATP synthesis coupled proton transport (GO:0015986) | 2.54363567 |
| 89 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.54363567 |
| 90 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.51329696 |
| 91 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.51329696 |
| 92 | DNA damage response, detection of DNA damage (GO:0042769) | 2.49061267 |
| 93 | tryptophan catabolic process (GO:0006569) | 2.48236419 |
| 94 | indole-containing compound catabolic process (GO:0042436) | 2.48236419 |
| 95 | indolalkylamine catabolic process (GO:0046218) | 2.48236419 |
| 96 | dendritic cell migration (GO:0036336) | 2.48182896 |
| 97 | mitochondrial RNA metabolic process (GO:0000959) | 2.47414367 |
| 98 | purine nucleotide salvage (GO:0032261) | 2.47294699 |
| 99 | positive regulation of T cell chemotaxis (GO:0010820) | 2.47288049 |
| 100 | regulation of T cell chemotaxis (GO:0010819) | 2.47288049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.90614757 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.35982469 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.12194914 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.62158394 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.55279299 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.44693557 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.32060256 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.18046259 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.09603837 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.07692686 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.05467389 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.03816961 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.92144430 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.89687530 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.65163298 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.63412789 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.62043938 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50602328 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.46462751 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.40793066 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.38691991 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.37409688 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.26823504 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.24246084 |
| 25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.23647750 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.14134638 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13513124 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.12351452 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.03998343 |
| 30 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.97935071 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97782328 |
| 32 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.86992333 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.83686460 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.73583056 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73515901 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72446840 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67503180 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.66832037 |
| 39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.62954529 |
| 40 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.61053799 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.57608740 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57209412 |
| 43 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55821482 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.54335369 |
| 45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.53670803 |
| 46 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.52708084 |
| 47 | GATA3_26560356_Chip-Seq_TH2_Human | 1.50170920 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.49988241 |
| 49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48726054 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.47793143 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47335907 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43545735 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33222886 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30756798 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30594261 |
| 56 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.30084640 |
| 57 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29667177 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29003826 |
| 59 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.22844833 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21609409 |
| 61 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.19957249 |
| 62 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12158605 |
| 63 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10548875 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.08294312 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05114207 |
| 66 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04808958 |
| 67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01669679 |
| 68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.00188206 |
| 69 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99412048 |
| 70 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.98253232 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98247675 |
| 72 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97085461 |
| 73 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95897683 |
| 74 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.95039404 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95006919 |
| 76 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94892226 |
| 77 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94859211 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94037298 |
| 79 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.93989505 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90496804 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90496804 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90331900 |
| 83 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.89107540 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 0.87409820 |
| 85 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.86660784 |
| 86 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85771232 |
| 87 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.85006141 |
| 88 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.84454048 |
| 89 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.84454048 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82026003 |
| 91 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.80926013 |
| 92 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.80686136 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.80550984 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.80361210 |
| 95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.79489878 |
| 96 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78624105 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78469104 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77706645 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.76563930 |
| 100 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.76134815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.06178977 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.89895675 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 3.54671096 |
| 4 | MP0009785_altered_susceptibility_to | 3.40180816 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.20931211 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 2.92819228 |
| 7 | MP0003724_increased_susceptibility_to | 2.74438182 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.74387090 |
| 9 | MP0001790_abnormal_immune_system | 2.72571455 |
| 10 | MP0005387_immune_system_phenotype | 2.72571455 |
| 11 | MP0004147_increased_porphyrin_level | 2.62296286 |
| 12 | MP0001800_abnormal_humoral_immune | 2.58103871 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.46961109 |
| 14 | MP0002102_abnormal_ear_morphology | 2.41262296 |
| 15 | MP0000685_abnormal_immune_system | 2.27012757 |
| 16 | MP0002723_abnormal_immune_serum | 2.18897135 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.18112771 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.18099208 |
| 19 | MP0003866_abnormal_defecation | 2.03642437 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 1.99788060 |
| 21 | MP0010094_abnormal_chromosome_stability | 1.99518167 |
| 22 | MP0002166_altered_tumor_susceptibility | 1.90913574 |
| 23 | MP0001819_abnormal_immune_cell | 1.90047101 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.88746569 |
| 25 | MP0005025_abnormal_response_to | 1.84578183 |
| 26 | MP0009764_decreased_sensitivity_to | 1.83661221 |
| 27 | MP0010368_abnormal_lymphatic_system | 1.82388261 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.81362251 |
| 29 | MP0000372_irregular_coat_pigmentation | 1.72570400 |
| 30 | MP0002006_tumorigenesis | 1.70048492 |
| 31 | MP0006082_CNS_inflammation | 1.66301796 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.60774120 |
| 33 | MP0002419_abnormal_innate_immunity | 1.58613077 |
| 34 | MP0003718_maternal_effect | 1.56069342 |
| 35 | MP0003436_decreased_susceptibility_to | 1.54343773 |
| 36 | MP0008007_abnormal_cellular_replicative | 1.53413080 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.48894570 |
| 38 | MP0002398_abnormal_bone_marrow | 1.46370986 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.44210505 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.43446096 |
| 41 | MP0000343_altered_response_to | 1.42112944 |
| 42 | MP0002405_respiratory_system_inflammati | 1.39683158 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.38242247 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.38060278 |
| 45 | MP0000716_abnormal_immune_system | 1.37913714 |
| 46 | MP0009697_abnormal_copulation | 1.37787317 |
| 47 | MP0003195_calcinosis | 1.33411372 |
| 48 | MP0002722_abnormal_immune_system | 1.31123584 |
| 49 | MP0004957_abnormal_blastocyst_morpholog | 1.30195925 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.29754610 |
| 51 | MP0008058_abnormal_DNA_repair | 1.23430519 |
| 52 | MP0001879_abnormal_lymphatic_vessel | 1.21648164 |
| 53 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21624747 |
| 54 | MP0002429_abnormal_blood_cell | 1.20886765 |
| 55 | MP0008469_abnormal_protein_level | 1.20083644 |
| 56 | MP0003186_abnormal_redox_activity | 1.19547858 |
| 57 | MP0004883_abnormal_blood_vessel | 1.19546428 |
| 58 | MP0006054_spinal_hemorrhage | 1.16142045 |
| 59 | MP0001873_stomach_inflammation | 1.15811999 |
| 60 | MP0006035_abnormal_mitochondrial_morpho | 1.13086342 |
| 61 | MP0003448_altered_tumor_morphology | 1.12678381 |
| 62 | MP0001243_abnormal_dermal_layer | 1.11205096 |
| 63 | MP0005310_abnormal_salivary_gland | 1.09675464 |
| 64 | MP0003786_premature_aging | 1.06314401 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.03737940 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.01494396 |
| 67 | MP0001853_heart_inflammation | 1.01204341 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 0.98795395 |
| 69 | MP0000249_abnormal_blood_vessel | 0.98080971 |
| 70 | MP0001986_abnormal_taste_sensitivity | 0.97980875 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.96762120 |
| 72 | MP0002163_abnormal_gland_morphology | 0.96704418 |
| 73 | MP0003646_muscle_fatigue | 0.93334146 |
| 74 | MP0001542_abnormal_bone_strength | 0.92414615 |
| 75 | MP0005165_increased_susceptibility_to | 0.91830416 |
| 76 | MP0005166_decreased_susceptibility_to | 0.90436340 |
| 77 | MP0001764_abnormal_homeostasis | 0.90392211 |
| 78 | MP0003077_abnormal_cell_cycle | 0.88769477 |
| 79 | MP0005645_abnormal_hypothalamus_physiol | 0.85934309 |
| 80 | MP0002139_abnormal_hepatobiliary_system | 0.83719177 |
| 81 | MP0004885_abnormal_endolymph | 0.81742202 |
| 82 | MP0003075_altered_response_to | 0.80612596 |
| 83 | MP0003303_peritoneal_inflammation | 0.75976435 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.75743921 |
| 85 | MP0008872_abnormal_physiological_respon | 0.75617096 |
| 86 | MP0004947_skin_inflammation | 0.75009856 |
| 87 | MP0003111_abnormal_nucleus_morphology | 0.73651129 |
| 88 | MP0005332_abnormal_amino_acid | 0.72463638 |
| 89 | MP0003045_fibrosis | 0.72100611 |
| 90 | MP0002736_abnormal_nociception_after | 0.71956309 |
| 91 | MP0009763_increased_sensitivity_to | 0.67226258 |
| 92 | MP0005395_other_phenotype | 0.65747104 |
| 93 | MP0002933_joint_inflammation | 0.65253811 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.63826577 |
| 95 | MP0005360_urolithiasis | 0.61755255 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.61278848 |
| 97 | MP0005367_renal/urinary_system_phenotyp | 0.61124003 |
| 98 | MP0000516_abnormal_urinary_system | 0.61124003 |
| 99 | MP0008873_increased_physiological_sensi | 0.61099211 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.60998686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 4.27615500 |
| 2 | IgM deficiency (HP:0002850) | 3.75832818 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.41648030 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.39143367 |
| 5 | Abnormality of B cell number (HP:0010975) | 3.35323008 |
| 6 | Prostate neoplasm (HP:0100787) | 3.34025708 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.23291269 |
| 8 | Abnormality of T cell physiology (HP:0011840) | 3.20214173 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.19616199 |
| 10 | Abnormality of the prostate (HP:0008775) | 3.18974172 |
| 11 | Increased CSF lactate (HP:0002490) | 3.18661338 |
| 12 | B lymphocytopenia (HP:0010976) | 3.18082138 |
| 13 | Recurrent bronchitis (HP:0002837) | 3.11162309 |
| 14 | Increased IgM level (HP:0003496) | 2.99135163 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 2.95939987 |
| 16 | Hepatic necrosis (HP:0002605) | 2.95837089 |
| 17 | Abnormality of T cells (HP:0002843) | 2.94947775 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 2.90919880 |
| 19 | IgA deficiency (HP:0002720) | 2.86951435 |
| 20 | Lipid accumulation in hepatocytes (HP:0006561) | 2.85598963 |
| 21 | Aplastic anemia (HP:0001915) | 2.85057583 |
| 22 | Abnormality of T cell number (HP:0011839) | 2.81047946 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80350677 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 2.80126688 |
| 25 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.79738363 |
| 26 | Increased serum lactate (HP:0002151) | 2.76646235 |
| 27 | Acute encephalopathy (HP:0006846) | 2.76196275 |
| 28 | Progressive macrocephaly (HP:0004481) | 2.64694536 |
| 29 | T lymphocytopenia (HP:0005403) | 2.59512622 |
| 30 | Methylmalonic aciduria (HP:0012120) | 2.53316871 |
| 31 | Stomatitis (HP:0010280) | 2.47621924 |
| 32 | Stomach cancer (HP:0012126) | 2.46405671 |
| 33 | Cerebral hemorrhage (HP:0001342) | 2.43907713 |
| 34 | Lactic acidosis (HP:0003128) | 2.43151196 |
| 35 | Cerebral palsy (HP:0100021) | 2.40870600 |
| 36 | Cerebral edema (HP:0002181) | 2.39515109 |
| 37 | Abnormality of the pons (HP:0007361) | 2.31028354 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.27183718 |
| 39 | Hypoplasia of the pons (HP:0012110) | 2.26757696 |
| 40 | Abnormal protein glycosylation (HP:0012346) | 2.26575586 |
| 41 | Abnormal glycosylation (HP:0012345) | 2.26575586 |
| 42 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.26575586 |
| 43 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.26575586 |
| 44 | Exertional dyspnea (HP:0002875) | 2.25008564 |
| 45 | Agammaglobulinemia (HP:0004432) | 2.22179721 |
| 46 | Methylmalonic acidemia (HP:0002912) | 2.21527776 |
| 47 | Redundant skin (HP:0001582) | 2.20567451 |
| 48 | Renal Fanconi syndrome (HP:0001994) | 2.20477299 |
| 49 | Myositis (HP:0100614) | 2.16620114 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.16551370 |
| 51 | Vasculitis (HP:0002633) | 2.15626748 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.14847617 |
| 53 | Eosinophilia (HP:0001880) | 2.14195982 |
| 54 | Bronchitis (HP:0012387) | 2.13968672 |
| 55 | Chronic diarrhea (HP:0002028) | 2.12923000 |
| 56 | Congenital, generalized hypertrichosis (HP:0004540) | 2.11227873 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.08955058 |
| 58 | Respiratory failure (HP:0002878) | 2.08824587 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.08239495 |
| 60 | Optic neuritis (HP:0100653) | 2.08239495 |
| 61 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08064297 |
| 62 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08064297 |
| 63 | Joint swelling (HP:0001386) | 2.07910894 |
| 64 | Recurrent abscess formation (HP:0002722) | 2.07676839 |
| 65 | Recurrent viral infections (HP:0004429) | 2.07607245 |
| 66 | Hemoptysis (HP:0002105) | 2.06874061 |
| 67 | Hematochezia (HP:0002573) | 2.05918458 |
| 68 | Abolished electroretinogram (ERG) (HP:0000550) | 2.05757874 |
| 69 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.05636889 |
| 70 | Parakeratosis (HP:0001036) | 2.04396527 |
| 71 | Neutropenia (HP:0001875) | 2.04193139 |
| 72 | Pancytopenia (HP:0001876) | 2.01631912 |
| 73 | Birth length less than 3rd percentile (HP:0003561) | 2.01348012 |
| 74 | Increased intramyocellular lipid droplets (HP:0012240) | 2.00697991 |
| 75 | Lethargy (HP:0001254) | 1.99560944 |
| 76 | Abnormality of eosinophils (HP:0001879) | 1.96028728 |
| 77 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95276088 |
| 78 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.95197643 |
| 79 | 3-Methylglutaconic aciduria (HP:0003535) | 1.94951070 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 1.93075238 |
| 81 | Colitis (HP:0002583) | 1.92071582 |
| 82 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.92040972 |
| 83 | Carpal bone hypoplasia (HP:0001498) | 1.91902052 |
| 84 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.87753914 |
| 85 | Recurrent cutaneous fungal infections (HP:0011370) | 1.87753914 |
| 86 | Abnormality of male internal genitalia (HP:0000022) | 1.87741950 |
| 87 | Neuroendocrine neoplasm (HP:0100634) | 1.85226192 |
| 88 | Meningitis (HP:0001287) | 1.84543159 |
| 89 | Gastrointestinal stroma tumor (HP:0100723) | 1.83787835 |
| 90 | Eczematoid dermatitis (HP:0000976) | 1.83544781 |
| 91 | Paralysis (HP:0003470) | 1.82617295 |
| 92 | Orchitis (HP:0100796) | 1.79058653 |
| 93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78595983 |
| 94 | Abnormality of alanine metabolism (HP:0010916) | 1.78595983 |
| 95 | Hyperalaninemia (HP:0003348) | 1.78595983 |
| 96 | Opisthotonus (HP:0002179) | 1.77890897 |
| 97 | Glucose intolerance (HP:0000833) | 1.76851521 |
| 98 | Granulocytopenia (HP:0001913) | 1.76498693 |
| 99 | Increased muscle lipid content (HP:0009058) | 1.76301745 |
| 100 | Palpitations (HP:0001962) | 1.76070897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 3.78597079 |
| 2 | TIE1 | 3.77121387 |
| 3 | VRK2 | 3.38128099 |
| 4 | TLK1 | 3.33145148 |
| 5 | MST4 | 2.78840887 |
| 6 | KDR | 2.71473777 |
| 7 | TSSK6 | 2.71059683 |
| 8 | BUB1 | 2.67202581 |
| 9 | EIF2AK3 | 2.65108696 |
| 10 | VRK1 | 2.63932568 |
| 11 | TESK2 | 2.57595971 |
| 12 | EIF2AK1 | 2.44652349 |
| 13 | ADRBK2 | 2.39557020 |
| 14 | TXK | 2.38321243 |
| 15 | BMPR2 | 2.24313320 |
| 16 | RIPK4 | 2.20498051 |
| 17 | GRK1 | 2.20046694 |
| 18 | SRPK1 | 2.06733626 |
| 19 | BCKDK | 1.75761285 |
| 20 | NUAK1 | 1.75701924 |
| 21 | MAP3K12 | 1.46936080 |
| 22 | PLK3 | 1.44991207 |
| 23 | TEC | 1.43452540 |
| 24 | STK16 | 1.33778615 |
| 25 | PLK4 | 1.33602291 |
| 26 | TAOK3 | 1.33255440 |
| 27 | TAF1 | 1.26559599 |
| 28 | TRIM28 | 1.25486961 |
| 29 | GRK7 | 1.19678564 |
| 30 | BMPR1B | 1.16652268 |
| 31 | MAP4K2 | 1.14141617 |
| 32 | EPHB2 | 1.12178326 |
| 33 | NEK1 | 1.10164689 |
| 34 | IKBKB | 1.08674466 |
| 35 | TBK1 | 1.07964085 |
| 36 | PBK | 1.07754137 |
| 37 | OXSR1 | 1.07469223 |
| 38 | BCR | 1.02576576 |
| 39 | DAPK1 | 1.01478393 |
| 40 | LIMK1 | 0.95850179 |
| 41 | MAP4K1 | 0.93863718 |
| 42 | TESK1 | 0.93608969 |
| 43 | CDK8 | 0.93331400 |
| 44 | KIT | 0.92162854 |
| 45 | SYK | 0.91736467 |
| 46 | MYLK | 0.89120728 |
| 47 | STK39 | 0.88201016 |
| 48 | EIF2AK2 | 0.84534969 |
| 49 | IRAK3 | 0.83409979 |
| 50 | JAK3 | 0.80192603 |
| 51 | FES | 0.78028982 |
| 52 | IKBKE | 0.76408365 |
| 53 | WEE1 | 0.75101101 |
| 54 | PAK4 | 0.74198867 |
| 55 | MKNK1 | 0.74109206 |
| 56 | ITK | 0.70061500 |
| 57 | CSNK1G3 | 0.69158661 |
| 58 | MKNK2 | 0.66462193 |
| 59 | WNK3 | 0.65420286 |
| 60 | FRK | 0.64021920 |
| 61 | TTK | 0.60969973 |
| 62 | CDC7 | 0.60255403 |
| 63 | MAP3K14 | 0.58324153 |
| 64 | PINK1 | 0.57848817 |
| 65 | SIK3 | 0.57214812 |
| 66 | RPS6KA5 | 0.57113034 |
| 67 | NME1 | 0.56634533 |
| 68 | MATK | 0.56016842 |
| 69 | PASK | 0.55223816 |
| 70 | CSNK1A1L | 0.54977396 |
| 71 | INSRR | 0.54004031 |
| 72 | CSNK1G1 | 0.53923025 |
| 73 | GRK6 | 0.53553423 |
| 74 | TYK2 | 0.51947484 |
| 75 | ALK | 0.51563180 |
| 76 | PNCK | 0.50670025 |
| 77 | CDK9 | 0.49766209 |
| 78 | PLK1 | 0.49713843 |
| 79 | CSNK1G2 | 0.47791563 |
| 80 | PLK2 | 0.47112401 |
| 81 | DAPK3 | 0.46508046 |
| 82 | PIK3CA | 0.46354411 |
| 83 | LCK | 0.46286433 |
| 84 | BLK | 0.45592616 |
| 85 | TGFBR1 | 0.44850582 |
| 86 | CSF1R | 0.44738824 |
| 87 | IRAK4 | 0.44421403 |
| 88 | PDK2 | 0.43719495 |
| 89 | LYN | 0.41945347 |
| 90 | DYRK2 | 0.41328273 |
| 91 | PRKCQ | 0.39351886 |
| 92 | MAPKAPK3 | 0.39226071 |
| 93 | ACVR1B | 0.39185776 |
| 94 | AURKB | 0.38929002 |
| 95 | NME2 | 0.38269322 |
| 96 | BTK | 0.38158510 |
| 97 | FGR | 0.37792359 |
| 98 | MAPKAPK5 | 0.36173860 |
| 99 | MAP3K9 | 0.34677127 |
| 100 | PIM1 | 0.33370143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.71552200 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.16788445 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.07882466 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.99759296 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.71146959 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.70249802 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.64364764 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.60321506 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.43619993 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16886388 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.15174973 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 2.12014628 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.06426070 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.01348833 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90977310 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90415676 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.89185584 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.86635484 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.84875021 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.74882837 |
| 21 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.47662380 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43535071 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.35819507 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31599326 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29969743 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29151908 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24803239 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.23474184 |
| 29 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.23389073 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21794835 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21406504 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15094009 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.14111560 |
| 34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.10392153 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.09765913 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.09470417 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06697741 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06355656 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06252702 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04352740 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03082747 |
| 42 | Huntingtons disease_Homo sapiens_hsa05016 | 1.00344995 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99518832 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.99027103 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96469386 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 0.93721786 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92960595 |
| 48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92491259 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91487348 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.89212806 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 0.88448364 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 0.87935316 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84142714 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83216946 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82063390 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81424707 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.78342154 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.77361385 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76952366 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69482263 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67918327 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67866957 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65902134 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.63398663 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60308915 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56847303 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55976625 |
| 68 | Ribosome_Homo sapiens_hsa03010 | 0.55233024 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53301486 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.52721323 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52394138 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51555322 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49844880 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49148310 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48462493 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 0.48166302 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47704058 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47225830 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47214955 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.44619551 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43574097 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40595200 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39952636 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.37694542 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35888743 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35340126 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.35047776 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33003315 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.31647566 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.31484867 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | 0.31469547 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30008097 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29759332 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.29367163 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28456287 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25995004 |
| 97 | Cell cycle_Homo sapiens_hsa04110 | 0.25317250 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.24261380 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.21967275 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21490891 |

